Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Long-term outcomes of high-dose-rate brachytherapy and external beam radiotherapy without hormone therapy for high-risk localized prostate cancer ; day:29 ; month:6 ; year:2024 ; pages:1-8
Japanese journal of radiology ; (29.6.2024), 1-8
- Creator
-
Kamitani, Nobuhiko
Watanabe, Kenta
Ikeda, Naoki
Kawata, Yujiro
Tokiya, Ryoji
Hayashi, Takafumi
Miyaji, Yoshiyuki
Tamada, Tsutomu
Katsui, Kuniaki
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11604-024-01621-4
- URN
-
urn:nbn:de:101:1-2409201051186.825623200858
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kamitani, Nobuhiko
- Watanabe, Kenta
- Ikeda, Naoki
- Kawata, Yujiro
- Tokiya, Ryoji
- Hayashi, Takafumi
- Miyaji, Yoshiyuki
- Tamada, Tsutomu
- Katsui, Kuniaki
- SpringerLink (Online service)
Other Objects (12)
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost
After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
Long-term oncologic outcomes of radiotherapy combined with maximal androgen blockade for localized, high-risk prostate cancer
High-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials
Two-Weekly High-Dose-Rate Brachytherapy Boost After External Beam Radiotherapy for Localized Prostate Cancer: Long-Term Outcome and Toxicity Analysis
The influence of Gleason score ≤ 6 histology on the outcome of high-risk localized prostate cancer after modern radiotherapy
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Stereotacticbody radiotherapy for high-risk prostate cancer: a systematic review
Classifying high-risk versus very high-risk prostate cancer: is it relevant to outcomes of conformal radiotherapy and androgen deprivation?
Biochemical control in intermediate- and high-risk prostate cancer after EBRT with and without brachytherapy boost